Oncolytic virotherapy (OV) is a promising treatment for high mortality cancers. To optimize the clinical outcome, non-invasive monitoring is essential. The goal of this work was to develop a deep-learning-based technique for quantitative and rapid molecular imaging of OV treatment response. Two CEST MR-fingerprinting protocols were sequentially implemented (105s each) and incorporated within a deep-reconstruction-network, trained to output the quantitative semi-solid and amide pool exchange parameters. The resulting molecular maps allowed early apoptosis detection in brain tumor OV mouse models. Clinical translation of CEST-MRF is demonstrated in a normal human subject and yielded parameters in good agreement with literature values.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords